# Adaptimmune Therapeutics PLC: Form SC 13D, filed Sep 17, 2018

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: SC 13D
- Filed: 2018-09-17
- Accepted by EDGAR: Sep 17, 2018, 15:45 ET
- Period: not reported
- Accession: 0001072613-18-000476
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000107261318000476/adaptimmune-13d_18249.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000107261318000476/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000107261318000476/adaptimmune-13d_18249.htm

Filed Sep 17, 2018.
Source: SEC EDGAR, the filing index for accession 0001072613-18-000476. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
